RPRX logo
Royalty Pharma plc(RPRX)
Closing price · checked 8:37 PM ETAbout this dataData status
$68.45▲0.73 (1.08%)
Extended:$67.65-0.80 (-1.17%)· 8:37 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Royalty Pharma plc (RPRX)

Operating Income

$1.50B

TTM · Period ending: · USD

RPRX logo

RPRX Operating Income

Latest reported$1.50B
RPRX Operating Income ($794.28M → $1.50B)
High-resolution chart · PNG

What is operating income?

Operating income is profit from the core business after operating costs, before interest and income taxes.

Compare operating income

RPRX operating income history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Royalty Pharma plc Operating Income — Annual fiscal periods (USD)
Period endingOperating Income (USD)Change
1,559,518,000+20.66%
1,292,444,000−13.38%
1,492,150,000+385.94%
307,065,000−78.54%
1,430,715,000−10.32%
1,595,399,000−39.18%
2,623,176,000+92.25%
1,364,446,000+45.20%
939,692,000+29.99%
722,874,000−8.99%
794,278,000—

Frequently asked questions: RPRX operating income

What is Royalty Pharma plc (RPRX)'s current operating income?

Royalty Pharma plc (RPRX)'s latest reported operating income (TTM) is $1.50B as of Sep 30, 2026. Operating income is profit from the core business after operating costs, before interest and income taxes.

How much historical operating income data is available for RPRX?

Stock Alarm Pro provides 11 dated annual fiscal periods observations for Royalty Pharma plc (RPRX)'s operating income, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare RPRX's operating income to peers or set an alert?

You can compare RPRX's operating income directly against sector peers (LLY, JNJ, ABBV, MRK) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on RPRX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.